Thakur Pooja, Gupta Vipan, Nanda Manpreet Singh, Bhatia Shenny
Department of Otorhinolaryngology and Head & Neck Surgery, Maharishi Markandeshwar Medical College and Hospital, Solan, Himachal Pradesh 173229 India.
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):1651-1660. doi: 10.1007/s12070-021-02808-1. Epub 2021 Aug 16.
The purpose of this study was assessment of reliability, validity & responsiveness of Hindi version of SNOT 22. 110 cases and controls were recruited in this prospective study. The internal consistency, test-retest reproducibility, construct & criterion validity, and responsiveness of Hindi version of SNOT 22 were assessed. Hindi SNOT 22 showed a good internal consistency (Cronbach's alpha (α) in cases = 0.823 and in controls = 0.868). Physical and Quality of life subscales also showed good internal consistency (α of 0.711 and 0.87 respectively). Test-retest reproducibility using Spearman's rank correlation coefficient (r) showed very high correlation (r = 0.939). There was significant difference in scores ( < 0.00001) between cases and controls (46.99 ± 13.97 and 07.58 ± 6.772 respectively). The mean pre and post-operative scores were 53.43 ± 12.241 and 20.50 ± 06.679 respectively with a significant difference ( = 0.000002) and a large effect size (Hedge's g = 2.34). Hindi SNOT 22 showed a moderate correlation with visual analogue scale (r = 0.663) and a low correlation with Lund Mackay staging (r = 0.388). The Hindi version of SNOT 22 is a valid, reliable and a responsive patient reported outcome measure instrument for assessment of chronic rhinosinusitis in adults. It retains most of the important characteristics of the source version (SNOT 22). This can be used as a clinical as well as research tool to aid in diagnosis, to assess quality of life as well as monitoring treatment strategies in the field of CRS in Hindi speaking patients.
The online version contains supplementary material available at 10.1007/s12070-021-02808-1.
本研究的目的是评估印地语版SNOT 22的信度、效度和反应度。在这项前瞻性研究中招募了110例病例和对照。评估了印地语版SNOT 22的内部一致性、重测信度、结构效度和效标效度以及反应度。印地语版SNOT 22显示出良好的内部一致性（病例组的克朗巴哈系数（α）=0.823，对照组的α=0.868）。身体和生活质量子量表也显示出良好的内部一致性（α分别为0.711和0.87）。使用斯皮尔曼等级相关系数（r）的重测信度显示出非常高的相关性（r=0.939）。病例组和对照组的得分存在显著差异（<0.00001）（分别为46.99±13.97和07.58±6.772）。术前和术后的平均得分分别为53.43±12.241和20.50±06.679，差异显著（=0.000002），效应量较大（赫奇斯g=2.34）。印地语版SNOT 22与视觉模拟量表显示出中等相关性（r=0.663），与伦德-麦凯分期显示出低相关性（r=0.388）。印地语版SNOT 22是一种有效、可靠且具有反应度的患者报告结局测量工具，用于评估成人慢性鼻窦炎。它保留了源版本（SNOT 22）的大部分重要特征。这可作为一种临床及研究工具，用于帮助诊断、评估生活质量以及监测印地语患者慢性鼻窦炎领域的治疗策略。
在线版本包含可在10.1007/s12070-021-02808-1获取的补充材料。
